FDA Inspection
New England Baptist HospitalNew England Baptist Hospital – FDA Inspection, Jul 27, 2009
Record Details
This FDA Inspection record concerns New England Baptist Hospital, with an inspection on July 27, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- New England Baptist Hospital
- Inspection Date
- July 27, 2009
- Product Type
- Biologics
View Company Profile
ID · 6fb24eb3-dff3-4da1-a456-bab681a812e4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 603425
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New England Baptist Hospital
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 28, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 27, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 8, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New England Baptist Hospital
- FDA Inspection 1030355 - 2017-09-29
- FDA Inspection 930232 - 2015-05-28
- FDA Inspection 820284 - 2013-02-27
- FDA Inspection 729297 - 2011-06-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.